Delpha Capital Management’s Allergan plc AGN Stock Holding History

Delpha Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-294	Closed	-$48K	–	1528
2017 Q4	$48K	Buy	+294	New	+$52.8K	0.05%	331

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Delpha Capital Management's AGN Position: Q1 2018 in Review

Delpha Capital Management sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 294 shares — an estimated $48K sold.

Delpha Capital Management first reported a position in AGN in Q4 2017 and held it in 1 quarter. The position peaked at $48K in Q4 2017. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

Delpha Capital Management reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Delpha Capital Management sold 294 Allergan plc shares in Q1 2018, an estimated $48K.
Delpha Capital Management first reported a position in Allergan plc in Q4 2017 and held it in 1 quarter.
Delpha Capital Management's Allergan plc position peaked at $48K in Q4 2017.
1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.